Sigrid Lundberg

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: NATURE GENETICS. 2023;55(7):1091-1105

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.

Kiryluk K; Sanchez-Rodriguez E; Zhou X-J; Zanoni F; Liu L; Mladkova N; Khan A; Marasa M; Zhang JY; Balderes O; Sanna-Cherchi S; Bomback AS; Canetta PA; Appel GB; Radhakrishnan J; Trimarchi H; Sprangers B; Cattran DC; Reich H; Pei Y; Ravani P; Galesic K; Maixnerova D; Tesar V; Stengel B; Metzger M; Canaud G; Maillard N; Berthoux F; Berthelot L; Pillebout E; Monteiro R; Nelson R; Wyatt RJ; Smoyer W; Mahan J; Samhar A-A; Hidalgo G; Quiroga A; Weng P; Sreedharan R; Selewski D; Davis K; Kallash M; Vasylyeva TL; Rheault M; Chishti A; Ranch D; Wenderfer SE; Samsonov D; Claes DJ; Akchurin O; Goumenos D; Stangou M; Nagy J; Kovacs T; Fiaccadori E; Amoroso A; Barlassina C; Cusi D; Del Vecchio L; Battaglia GG; Bodria M; Boer E; Bono L; Boscutti G; Caridi G; Lugani F; Ghiggeri G; Coppo R; Peruzzi L; Esposito V; Esposito C; Feriozzi S; Polci R; Frasca G; Galliani M; Garozzo M; Mitrotti A; Gesualdo L; Granata S; Zaza G; Londrino F; Magistroni R; Pisani I; Magnano A; Marcantoni C; Messa P; Mignani R; Pani A; Ponticelli C; Roccatello D; Salvadori M; Salvi E; Santoro D; Gembillo G; Savoldi S; Spotti D; Zamboli P; Izzi C; Alberici F; Delbarba E; Florczak M; Krata N; Mucha K; Pączek L; Niemczyk S; Moszczuk B; Pańczyk-Tomaszewska M; Mizerska-Wasiak M; Perkowska-Ptasińska A; Bączkowska T; Durlik M; Pawlaczyk K; Sikora P; Zaniew M; Kaminska D; Krajewska M; Kuzmiuk-Glembin I; Heleniak Z; Bullo-Piontecka B; Liberek T; Dębska-Slizien A; Hryszko T; Materna-Kiryluk A; Miklaszewska M; Szczepańska M; Dyga K; Machura E; Siniewicz-Luzeńczyk K; Pawlak-Bratkowska M; Tkaczyk M; Runowski D; Kwella N; Drożdż D; Habura I; Kronenberg F; Prikhodina L; van Heel D; Fontaine B; Cotsapas C; Wijmenga C; Franke A; Annese V; Gregersen PK; Parameswaran S; Weirauch M; Kottyan L; Harley JB; Suzuki H; Narita I; Goto S; Lee H; Kim DK; Kim YS; Park J-H; Cho B; Choi M; Van Wijk A; Huerta A; Ars E; Ballarin J; Lundberg S; Vogt B; Mani L-Y; Caliskan Y; Barratt J; Abeygunaratne T; Kalra PA; Gale DP; Panzer U; Rauen T; Floege J; Schlosser P; Ekici AB; Eckardt K-U; Chen N; Xie J; Lifton RP; Loos RJF; Kenny EE; Ionita-Laza I; Köttgen A; Julian BA; Novak J; Scolari F; Zhang H; Gharavi AG
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023;38(Supplement_1):gfad063c_4484

#4484 EFFECT OF BROCCOLI SPROUT EXTRACT IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE (INITIATE) - DESIGN AND BASELINE DATA

Avesani CM; Swartling O; Svensson ME; Heimbürger O; Lundberg S; Guron G; Jonsson PA; Segelmark M; Evans M; Stenvinkel P
Article: NEPHRON. 2022;146(6):573-583

Long-Term Outcomes of Patients with IgA Nephropathy Categorized by the International IgAN Risk Prediction Tool and by the Degree of Hematuria at Diagnosis.

Ebbestad R; Sanaei Nurmi M; Lundberg S
Article: JOURNAL OF NEPHROLOGY. 2021;34(5):1591-1598

Pregnancy outcomes in women with immunoglobulin A nephropathy: a nationwide population-based cohort study.

Jarrick S; Lundberg S; Stephansson O; Symreng A; Bottai M; Höijer J; Ludvigsson JF
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2021;36(8):1389-1398

The switch from proteasome to immunoproteasome is increased in circulating cells of patients with fast progressive immunoglobulin A nephropathy and associated with defective CD46 expression.

Peruzzi L; Coppo R; Cocchi E; Loiacono E; Bergallo M; Bodria M; Vergano L; Krutova A; Russo ML; Amore A; Lundberg S; Maixerova D; Tesar V; Perkowska-Ptasińska A; Durlik M; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Mizerska-Wasiak M; Gesualdo L; Montemurno E; Benozzi L; Cusinato S; Hryszko T; Klinger M; Kamińska D; Krajewska M; VALIGA study group of the ERA-EDTA Immunonephrolog
Article: BMC NEPHROLOGY. 2021;22(1):165

Immunoglobulin A nephropathy and ischemic heart disease: a nationwide population-based cohort study.

Jarrick S; Lundberg S; Sundström J; Symreng A; Warnqvist A; Ludvigsson JF
Article: KIDNEY INTERNATIONAL. 2021;99(5):1179-1188

Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy.

Schena FP; Anelli VW; Trotta J; Di Noia T; Manno C; Tripepi G; D'Arrigo G; Chesnaye NC; Russo ML; Stangou M; Papagianni A; Zoccali C; Tesar V; Coppo R; members of the VALIGA study
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2021;32(2):436-447

Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.

Canney M; Barbour SJ; Zheng Y; Coppo R; Zhang H; Liu Z-H; Matsuzaki K; Suzuki Y; Katafuchi R; Reich HN; Cattran D; International IgA Nephropathy Network; International IgA Nephropathy Network Investigator
Article: PLOS ONE. 2021;16(3):e0248056

B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.

Sendic S; Mansouri L; Lundberg S; Nopp A; Jacobson SH; Lundahl J
Article: KIDNEY INTERNATIONAL. 2020;98(4):1009-1019

Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool.

Barbour SJ; Canney M; Coppo R; Zhang H; Liu Z-H; Suzuki Y; Matsuzaki K; Katafuchi R; Induruwage D; Er L; Reich HN; Feehally J; Barratt J; Cattran DC; International IgA Nephropathy Network
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020;35(6):1002-1009

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C; ERA-EDTA Immunonephrology Working Group
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(Supplement_1):gfz106.fp221

FP221B CELL AND MONOCYTE PHENOTYPING IN IGA NEPHROPATHY: A QUICK ASSET TO INVESTIGATE THE IMMUNE STATUS IN PATIENTS WITH IGA NEPHROPATHY

Sendic S; Mansouri L; Lundberg S; Anna NS; Stefan HJ; Joachim L
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2019;30(5):866-876

Mortality in IgA Nephropathy: A Nationwide Population-Based Cohort Study.

Jarrick S; Lundberg S; Welander A; Carrero J-J; Höijer J; Bottai M; Ludvigsson JF
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34(4):587-596

Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy.

Coppo R; Peruzzi L; Loiacono E; Bergallo M; Krutova A; Russo ML; Cocchi E; Amore A; Lundberg S; Maixnerova D; Tesar V; Perkowska-Ptasińska A; Durlik M; Goumenos D; Gerolymos M; Galesic K; Toric L; Papagianni A; Stangou M; Mizerska-Wasia Membek M; Gesualdo L; Montemurno E; Benozzi L; Cusinato S; Hryszko T; Klinger M; Kamińska D; Krajewska M; VALIGA Study Group of the ERA-EDTA Immunonephrolog
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(suppl_3):iii140

SP104IS THERE LONG-TERM VALUE OF PATHOLOGY SCORING IN IGA NEPHROPATHY? A VALIGA UPDATE

Coppo R; D'Arrigo G; Tripepi G; Russo M; Roberts ISD; Bellur S; Cattran D; Cook T; Feehally J; Tesar V; Maixnerova D; Lundberg S; Di Palma A; Emma F; Rollino C; Praga M; Biancone L; Pani A; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Ballarin J
Article: CLINICAL KIDNEY JOURNAL. 2017;10(1):20-26

B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis.

Lundberg S; Westergren E; Smolander J; Bruchfeld A
Article: PEDIATRIC NEPHROLOGY. 2017;32(1):139-150

Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts ISD; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
Article: CLINICAL EPIDEMIOLOGY. 2017;9:67-73

Clinical validation of immunoglobulin A nephropathy diagnosis in Swedish biopsy registers.

Jarrick S; Lundberg S; Welander A; Fored CM; Ludvigsson JF
Article: JOURNAL OF NEPHROLOGY. 2016;29(5):711-714

Diarrhea-associated hemolytic uremic syndrome with severe neurological manifestations treated with IgG depletion through immunoadsorption.

Flam B; Sackey P; Berge A; Zachau AC; Brink B; Lundberg S
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i46

MO041IMMUNOPROTEASOME PSMB8 MRNA EXPRESSION IS CORRELATED WITH ANNUAL LOSS OF GLOMERULAR FILTRATION RATE (EGFR SLOPE) IN IGAN PATIENTS ENROLLED IN VALIGA STUDY

Peruzzi L; Loiacono E; Russo ML; Amore A; Lundberg S; Maixnerova D; Tesar V; Perkowska-Ptasińska A; Goumenos D; Gerolymos M; Galesic K; Toric L; Papagianni A; Stangou M; Mizerska-Wasiak M; Gesualdo L; Montemurno E; Cusinato S; Benozzi L; Hryszko T; Kaminska D; Krajewska M; Krutova A; Coppo R; EDTA FVIWE
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31(suppl_1):i39

MO028PROGRESSIVE IGA NEPHPHROPATHY AND DEFECTIVE COMPLEMENT INHIBITOR CD46 MRNA EXPRESSION

Coppo R; Peruzzi L; Loiacono E; Bergallo M; Russo ML; Amore A; Lundberg S; Maixnerova D; Tesar V; Perkowska-Ptasińska A; Goumenos D; Gerolymos M; Galesic K; Toric L; Papagianni A; Stangou M; Mizerska-Wasiak M; Gesualdo L; Montemurno E; Benozzi L; Cusinato S; Hryszko T; Krajewska M; Krutova A; EDTA FVIWE
Article: NEPHRON. 2016;132(1):15-24

Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy.

Feehally J; Coppo R; Troyanov S; Bellur SS; Cattran D; Cook T; Roberts ISD; Verhave JC; Camilla R; Vergano L; Egido J; Wiecek A; Karkoszka H; Tesar V; Maixnerova D; Ots-Rosenberg M; Quaglia M; Rollino C; Magistroni R; Cusinato S; Cravero R; Peruzzi L; Lundberg S; Gesualdo L; Cancarini G; Feriozzi S; Ferrario F; VALIGA study of ERA-EDTA Immunonephrology Working
Article: KIDNEY INTERNATIONAL. 2016;89(1):167-175

The MEST score provides earlier risk prediction in lgA nephropathy.

Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts ISD; Feehally J; Herzenberg AM; Cattran DC; Oxford Derivation, North American Validation and V; Oxford Derivation North American Validation and VA
Article: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2015;26(9):2248-2258

Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.

Tesar V; Troyanov S; Bellur S; Verhave JC; Cook HT; Feehally J; Roberts ISD; Cattran D; Coppo R; VALIGA study of the ERA-EDTA Immunonephrology Work
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30(suppl_3):iii104

FP112THE PROTEASOME TO IMMUNOPROTEASOME SWITCH IN IGA NEPHROPATHY AND ITS GENETIC CONTROL: A POST-VALIGA EUROPEAN RESEARCH STUDY

Peruzzi L; Loiacono E; Bodria M; Amore A; Vergano L; Lundberg S; Perkowska-Ptasińska A; Goumenos D; Galesic K; Papagiannis A; Stangou M; Gharavi A; Kiryluk K; Coppo R
Article: KIDNEY INTERNATIONAL. 2014;86(4):828-836

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.

Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts ISD; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A; VALIGA study of the ERA-EDTA Immunonephrology Work
Article: DIABETOLOGIA. 2014;57(7):1339-1345

Risk of renal disease in patients with both type 1 diabetes and coeliac disease.

Mollazadegan K; Fored M; Lundberg S; Ludvigsson J; Ekbom A; Montgomery SM; Ludvigsson JF
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2014;63(2):289-293

Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease.

Ohlsson S; Herlitz H; Lundberg S; Selga D; Mölne J; Wieslander J; Segelmark M
Article: HUMAN IMMUNOLOGY. 2013;74(8):957-960

Genetic evidence for involvement of adaptive immunity in the development of IgA nephropathy: MHC class II alleles are protective in a Caucasian population.

Vuong MT; Lundberg S; Gunnarsson I; Wramner L; Lundström E; Fernström A; Alfredsson L; Jacobson SH; Padyukov L
Article: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2012;7(5):727-734

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy.

Lundberg S; Qureshi AR; Olivecrona S; Gunnarsson I; Jacobson SH; Larsson TE
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012;27(5):1916-1923

Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.

Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2012;46(2):148-155

Impact of the apolipoprotein B/apolipoprotein A-I ratio on renal outcome in immunoglobulin A nephropathy.

Lundberg S; Gunnarsson I; Jacobson SH
Article: KIDNEY INTERNATIONAL. 2010;78(12):1281-1287

Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.

Vuong MT; Hahn-Zoric M; Lundberg S; Gunnarsson I; van Kooten C; Wramner L; Seddighzadeh M; Fernström A; Hanson LÅ; Do LT; Jacobson SH; Padyukov L
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2010;304(21):2381-2388

Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.

Hiemstra TF; Walsh M; Mahr A; Savage CO; de Groot K; Harper L; Hauser T; Neumann I; Tesar V; Wissing K-M; Pagnoux C; Schmitt W; Jayne DRW; European Vasculitis Study Group (EUVAS)
Article: PLOS ONE. 2010;5(5):e10559

Genetic risk factors in lupus nephritis and IgA nephropathy--no support of an overlap.

Vuong MT; Gunnarsson I; Lundberg S; Svenungsson E; Wramner L; Fernström A; Syvänen A-C; Do LT; Jacobson SH; Padyukov L
Article: CLINICAL NEPHROLOGY. 2010;73(3):221-228

Atorvastatin-induced modulation of monocyte respiratory burst in vivo in patients with IgA nephropathy: a chronic inflammatory kidney disease.

Lundberg S; Lundahl J; Gunnarsson I; Jacobson SH
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2009;24(10):3061-3067

Genetic variation in the transforming growth factor-beta1 gene is associated with susceptibility to IgA nephropathy.

Vuong MT; Lundberg S; Gunnarsson I; Wramner L; Seddighzadeh M; Hahn-Zoric M; Fernström A; Hanson LA; Do LT; Jacobson SH; Padyukov L
Journal article: BIOCHEMICAL PHARMACOLOGY. 1990;40(2):239-243

Oxidant-induced changes in the cellular energy homeostasis. A study with 3,5-dimethyl N-acetyl-p-benzoquinone imine and isolated hepatocytes.

Rundgren M; Harder S; Nelson SD; Andersson BS
Visa fler

Alla övriga publikationer

Editorial comment: LANCET. 2023;401(10388):1548-1550

We can go further in non-immunosuppressive treatment of IgA nephropathy.

Lundberg S; Bergen K
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023;38:I678

EFFECT OF BROCCOLI SPROUT EXTRACT IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE (INITIATE) - DESIGN AND BASELINE DATA

Avesani CM; Swartling O; Svensson ME; Heimburger O; Lundberg S; Guron G; Jonsson PA; Segelmark M; Evans M; Stenvinkel P
Editorial comment: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37(6):1195-1197

Indication for corticosteroids in IgA nephropathy: validation in the European VALIGA cohort of a treatment score based on the Oxford classification.

Cambier A; Troyanov S; Tesar V; Coppo R; Validation Study of Oxford Classification (VALIGA)
Corrigendum: CLINICAL EPIDEMIOLOGY. 2022;14:769

Erratum: Clinical Validation of Immunoglobulin A Nephropathy Diagnosis in Swedish Biopsy Registers [Corrigendum].
Preprint: MEDRXIV. 2021

GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy

Kiryluk K; Sanchez-Rodriguez E; Zhou X-J; Zanoni F; Liu L; Mladkova N; Khan A; Marasa M; Zhang JY; Balderes O; Sanna-Cherchi S; Bomback AS; Canetta PA; Appel GB; Radhakrishnan J; Trimarchi H; Sprangers B; Cattran DC; Reich H; Pei Y; Ravani P; Galesic K; Maixnerova D; Tesar V; Stengel B; Metzger M; Canaud G; Maillard N; Berthoux F; Berthelot L; Pillebout E; Monteiro R; Nelson R; Wyatt R; Smoyer W; Mahan J; Samhar A-A; Hidalgo G; Quiroga A; Weng P; Sreedharan R; Selewski D; Davis K; Kallash M; Vasylyeva TL; Rheault M; Chishti A; Ranch D; Wenderfer SE; Samsonov D; Claes DJ; Oleh A; Goumenos D; Stangou M; Nagy J; Kovacs T; Fiaccadori E; Amoroso A; Barlassina C; Cusi D; Del Vecchio L; Battaglia GG; Bodria M; Boer E; Bono L; Boscutti G; Caridi G; Lugani F; Ghiggeri G; Coppo R; Peruzzi L; Esposito V; Esposito C; Feriozzi S; Polci R; Frasca G; Galliani M; Garozzo M; Mitrotti A; Gesualdo L; Granata S; Zaza G; Londrino F; Magistroni R; Pisani I; Magnano A; Marcantoni C; Messa P; Mignani R; Pani A; Ponticelli C; Roccatello D; Salvadori M; Salvi E; Santoro D; Gembillo G; Savoldi S; Spotti D; Zamboli P; Izzi C; Alberici F; Delbarba E; Florczak M; Krata N; Mucha K; Pączek L; Niemczyk S; Moszczuk B; Pańczyk-Tomaszewska M; Mizerska-Wasiak M; Perkowska-Ptasińska A; Bączkowska T; Durlik M; Pawlaczyk K; Sikora P; Zaniew M; Kaminska D; Krajewska M; Kuzmiuk-Glembin I; Heleniak Z; Bullo-Piontecka B; Liberek T; Dębska-Slizien A; Hryszko T; Materna-Kiryluk A; Miklaszewska M; Szczepańska M; Dyga K; Machura E; Siniewicz-Luzeńczyk K; Pawlak-Bratkowska M; Tkaczyk M; Runowski D; Kwella N; Drożdż D; Habura I; Kronenberg F; Prikhodina L; van Heel D; Fontaine B; Cotsapas C; Wijmenga C; Franke A; Annese V; Gregersen PK; Parameswaran S; Weirauch M; Kottyan L; Harley JB; Suzuki H; Narita I; Goto S; Lee H; Kim DK; Kim YS; Park J-H; Cho B; Choi M; Van Wijk A; Huerta A; Ars E; Ballarin J; Lundberg S; Vogt B; Mani L-Y; Caliskan Y; Barratt J; Abeygunaratne T; Kalra PA; Gale DP; Panzer U; Rauen T; Floege J; Schlosser P; Ekici AB; Eckardt K-U; Chen N; Xie J; Lifton RP; Loos RJF; Kenny EE; Ionita-Laza I; Köttgen A; Julian B; Novak J; Scolari F; Zhang H; Gharavi AG
Preprint: AUTHOREA. 2020

B CELL AND MONOCYTE PHENOTYPING A QUICK ASSET TO INVESTIGATE THE IMMUNE STATUS IN PATIENTS WITH IGA NEPHROPATHY

Sendic S; Mansouri L; Lundberg S; Nopp A; Jacobson S; Lundahl J
Published conference paper: JAMA INTERNAL MEDICINE. 2019;179(7):942-952

Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.

Barbour SJ; Coppo R; Zhang H; Liu Z-H; Suzuki Y; Matsuzaki K; Katafuchi R; Er L; Espino-Hernandez G; Kim SJ; Reich HN; Feehally J; Cattran DC; International IgA Nephropathy Network
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2019;34:117

B CELL AND MONOCYTE PHENOTYPING IN IGA NEPHROPATHY: A QUICK ASSET TO INVESTIGATE THE IMMUNE STATUS IN PATIENTS WITH IGA NEPHROPATHY

Sendic S; Mansouri L; Lundberg S; Anna NS; Stefan HJ; Joachim L
Corrigendum: PEDIATRIC NEPHROLOGY. 2017;32(1):193-194

Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts ISD; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; Smerud HK; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32

IS THERE LONG-TERM VALUE OF PATHOLOGY SCORING IN IGA NEPHROPATHY? A VALIGA UPDATE

Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Lundberg S; Di Palma AM; Emma F; Rollino C; Praga M; Biancone L; Pani A; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Ballarin J
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:46

IMMUNOPROTEASOME PSMB8 MRNA EXPRESSION IS CORRELATED WITH ANNUAL LOSS OF GLOMERULAR FILTRATION RATE (EGFR SLOPE) IN IGAN PATIENTS ENROLLED IN VALIGA STUDY

Peruzzi L; Loiacono E; Russo ML; Amore A; Lundberg S; Maixnerova D; Tesar V; Perkowska-Ptasinska A; Goumenos D; Gerolymos M; Galesic K; Toric L; Papagianni A; Stangou M; Mizerska-Wasiak M; Gesualdo L; Montemurno E; Cusinato S; Benozzi L; Hryszko T; Kaminska D; Krajewska M; Krutova A; Coppo R
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2016;31:39

PROGRESSIVE IGA NEPHPHROPATHY AND DEFECTIVE COMPLEMENT INHIBITOR CD46 MRNA EXPRESSION

Coppo R; Peruzzi L; Loiacono E; Bergallo M; Russo ML; Amore A; Lundberg S; Maixnerova D; Tesar V; Perkowska-Ptasinska A; Goumenos D; Gerolymos M; Galesic K; Toric L; Papagianni A; Stangou M; Mizerska-Wasiak M; Gesualdo L; Montemurno E; Benozzi L; Cusinato S; Hryszko T; Krajewska M; Krutova A
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2015;30

THE PROTEASOME TO IMMUNOPROTEASOME SWITCH IN IGA NEPHROPATHY AND ITS GENETIC CONTROL: A POST-VALIGA EUROPEAN RESEARCH STUDY

Peruzzi L; Loiacono E; Bodria M; Amore A; Vergano L; Lundberg S; Perkowska-Ptasinska A; Goumenos D; Galesic K; Papagiannis A; Stangou M; Gharavi A; Kiryluk K; Coppo R
Conference publication: PEDIATRIC NEPHROLOGY. 2015;30(9):1554

PROTEASOME TO IMMUNOPROTEASOME SWITCH IN IGA NEPHROPATHYAND ITS GENETIC CONTROL: A POST-VALIGA EUROPEAN RESEARCH STUDY

Peruzzi L; Loiacono E; Bodria M; Amore A; Lundberg S; Vergano L; Perkowska-Ptasinska A; Goumenos D; Galesic K; Papagiannis A; Stangou M; Gharavi A; Kiryluk K; Coppo R
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014;29:188

ABERRANT GLYCOSYLATION OF IGA MEASURED BY HELIX ASPERSA LECTIN BINDING OR GALACTIN-8 BINDING ASSAYS DOES NOT PREDICT PROGNOSIS IN SWEDISH PATIENTS WITH IGA NEPHROPATHY

Lundberg S; Carlsson MC; Leffler H; Pahlsson P; Segelmark M
Thesis / dissertation: 2012

Factors predicting progression of chronic kidney disease in IgA nephropathy

Lundberg, Sigrid
Meeting abstract: CLINICAL IMMUNOLOGY. 2010;135:S114

Genetic Study of IgA Nephropathy and Lupus Nephritis: No Overlap in Genetic Risk Factors

Vuong M; Gunnarsson I; Lundberg S; Wramner L; Fernstrom A; Syvanen A-C; Do L; Jacobson S; Padyukov L
Meeting abstract: CLINICAL IMMUNOLOGY. 2008;127:S151

Evidence for genetic regulation of Fc alpha receptor (CD89) expression:: Study of soluble CD89 in plasma of IgA nephropathy patients and healthy controls

Hahn-Zoric M; Vuong M; Lundberg S; Wramner L; Ahlmen J; Hanson LA; Gunnarsson I; Jacobson S; Padyukov L

Anställningar

Anknuten till Forskning, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2012

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI